Adrienne Farid - Mar 6, 2024 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Role
Chief Operations Officer
Signature
/s/ Adrienne Farid
Stock symbol
IPSC
Transactions as of
Mar 6, 2024
Transactions value $
-$214,562
Form type
4
Date filed
3/8/2024, 06:29 PM
Previous filing
Feb 21, 2024
Next filing
Mar 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IPSC Common Stock Options Exercise $31.6K +30.7K +26.88% $1.03 145K Mar 6, 2024 Direct F1
transaction IPSC Common Stock Sale -$152K -30.7K -21.19% $4.96 114K Mar 6, 2024 Direct F1, F2
transaction IPSC Common Stock Options Exercise $23.5K +22.8K +20% $1.03 137K Mar 7, 2024 Direct F1
transaction IPSC Common Stock Sale -$117K -22.8K -16.67% $5.14 114K Mar 7, 2024 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IPSC Stock Option (right to buy) Options Exercise $0 -30.7K -13.81% $0.00 191K Mar 6, 2024 Common Stock 30.7K $1.03 Direct F1, F4
transaction IPSC Stock Option (right to buy) Options Exercise $0 -22.8K -11.92% $0.00 169K Mar 7, 2024 Common Stock 22.8K $1.03 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.85 to $5.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3 to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.87 to $5.48, inclusive.
F4 The option is fully vested and exercisable.